1-2 of 2
Jacquelyn Hedlund, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1/2 Trial of TH-302 and Dexamethasone without or with Bortezomib (TBorD) in Patients with Relapsed/Refractory Multiple Myeloma

Jacob P. Laubach, MD, Noopur S. Raje, MD, Andrew J. Yee, MD, Philippe Armand, MD PhD, Robert L. Schlossman, MD, Jacalyn Rosenblatt, MD, Jeffrey Matous, MD, Jacquelyn Hedlund, MD, Michael G Martin, MD, Craig Reynolds, MD, Kenneth H. Shain, MD PhD, Ira Zackon, MD, Laura V. Stampleman, MD, Erica N Boswell, BS, Stacey Chuma, BSN, Rebecca Liguori, MS, Stephanie Mar, Damian Handisides, Stew Kroll, Kenneth C. Anderson, MD, Paul G. Richardson, Irene M. Ghobrial, MD
Journal: Blood
Blood (2014) 124 (21): 2142.
https://doi.org/10.1182/blood.V124.21.2142.2142
Published: 2014
Journal Articles

A Multicenter Phase I Study of CTLA-4 Blockade with Ipilimumab for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation

Matthew S. Davids, MD, Haesook T. Kim, PhD, Caitlin L. Costello, MD, David Avigan, MD, Yi-Bin Chen, MD, Philippe Armand, MD PhD, Edwin P. Alyea, MD, Jacquelyn Hedlund, MD, Peter A. McSweeney, MD, Rebecca Liguori, MS, Jerome Ritz, MD, Edward D. Ball, MD, Asad Bashey, MD PhD, Robert J Soiffer, MD
Journal: Blood
Blood (2014) 124 (21): 3964.
https://doi.org/10.1182/blood.V124.21.3964.3964
Published: 2014